Amgen Says FDA Has Extended Review Period for Lumakras in Combination With Vectibix for Treating Some Colorectal Cancer Patients
安進表示,FDA已延長Lumakras與Vectibix聯合治療部分結直腸癌患者的審評期
Amgen Says FDA Has Extended Review Period for Lumakras in Combination With Vectibix for Treating Some Colorectal Cancer Patients
安進表示,FDA已延長Lumakras與Vectibix聯合治療部分結直腸癌患者的審評期
譯文內容由第三人軟體翻譯。